Private Lenders Plan €1.6 Billion Refinancing for Belgium’s SERB

Private credit lenders including Intermediate Capital Group Plc, Goldman Sachs Asset Management and the direct-lending unit of JPMorgan Chase & Co. are among firms in early-stage talks to provide roughly €1.6 billion ($1.8 billion) to refinance the debt of Belgian drugmaker SERB Pharmaceuticals.

Direct lenders are working together on a potential debt package with private equity owner Charterhouse Capital Partners, set to be split between €1.3 billion of drawn debt and approximately €300 million of undrawn facilities, people with knowledge of the matter said.

Charterhouse, ICG, JPMorgan, GSAM and the company declined to comment. Talks are still exploratory and ...